Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 31% ± 14% | |
peripheral blood | 12 studies | 23% ± 6% | |
kidney | 8 studies | 25% ± 3% | |
intestine | 8 studies | 25% ± 12% | |
eye | 5 studies | 33% ± 16% | |
lymph node | 5 studies | 25% ± 7% | |
pancreas | 4 studies | 50% ± 19% | |
uterus | 4 studies | 31% ± 15% | |
liver | 4 studies | 34% ± 25% | |
breast | 4 studies | 25% ± 5% | |
brain | 4 studies | 21% ± 5% | |
bone marrow | 3 studies | 18% ± 0% | |
prostate | 3 studies | 25% ± 9% | |
thymus | 3 studies | 37% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 2329.62 | 258 / 258 | 100% | 114.20 | 230 / 230 |
brain | 100% | 2255.81 | 2642 / 2642 | 100% | 88.75 | 705 / 705 |
esophagus | 100% | 1665.47 | 1445 / 1445 | 100% | 104.23 | 183 / 183 |
liver | 100% | 998.58 | 226 / 226 | 100% | 86.37 | 406 / 406 |
ovary | 100% | 1481.26 | 180 / 180 | 100% | 165.50 | 430 / 430 |
uterus | 100% | 1751.19 | 170 / 170 | 100% | 109.14 | 459 / 459 |
breast | 100% | 1882.83 | 459 / 459 | 100% | 140.06 | 1117 / 1118 |
thymus | 100% | 1730.34 | 653 / 653 | 100% | 83.36 | 604 / 605 |
prostate | 100% | 1744.83 | 245 / 245 | 100% | 85.47 | 501 / 502 |
lung | 100% | 1656.73 | 576 / 578 | 100% | 106.97 | 1155 / 1155 |
bladder | 100% | 1813.90 | 21 / 21 | 100% | 113.78 | 502 / 504 |
kidney | 100% | 2009.37 | 89 / 89 | 99% | 65.46 | 895 / 901 |
skin | 100% | 1595.62 | 1807 / 1809 | 99% | 99.05 | 469 / 472 |
stomach | 100% | 1457.87 | 359 / 359 | 99% | 111.16 | 283 / 286 |
intestine | 100% | 1733.83 | 966 / 966 | 98% | 94.26 | 517 / 527 |
pancreas | 99% | 742.13 | 324 / 328 | 99% | 74.33 | 176 / 178 |
blood vessel | 100% | 2354.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 90.84 | 29 / 29 |
spleen | 100% | 1464.52 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 92.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 105.37 | 1 / 1 |
adipose | 100% | 1849.50 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 852.90 | 793 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1245.54 | 847 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 70.68 | 75 / 80 |
peripheral blood | 40% | 781.10 | 367 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006360 | Biological process | transcription by RNA polymerase I |
GO_0006356 | Biological process | regulation of transcription by RNA polymerase I |
GO_0006383 | Biological process | transcription by RNA polymerase III |
GO_0005736 | Cellular component | RNA polymerase I complex |
GO_0005665 | Cellular component | RNA polymerase II, core complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005666 | Cellular component | RNA polymerase III complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0001055 | Molecular function | RNA polymerase II activity |
GO_0001056 | Molecular function | RNA polymerase III activity |
GO_0001054 | Molecular function | RNA polymerase I activity |
GO_0005515 | Molecular function | protein binding |
GO_0008270 | Molecular function | zinc ion binding |
Gene name | POLR2K |
Protein name | RNA polymerase II, I and III subunit K DNA-directed RNA polymerases I, II, and III subunit RPABC4 (RNA polymerases I, II, and III subunit ABC4) (ABC10-alpha) (DNA-directed RNA polymerase II subunit K) (RNA polymerase II 7.0 kDa subunit) (RPB7.0) (RPB10alpha) |
Synonyms | |
Description | FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Common component of RNA polymerases I, II and III which synthesize ribosomal RNA precursors, mRNA precursors and many functional non-coding RNAs, and a small RNAs, such as 5S rRNA and tRNAs, respectively. . |
Accessions | E5RGX2 ENST00000353107.8 P53803 ENST00000522439.1 |